Back to Results
First PageMeta Content
Stem cells / Diabetes / Diabetic foot ulcer / Wound / Maggot therapy / Cell therapy / Chronic wound / Ulcer / Medicine / Biology / Traumatology


Grafix® Demonstrates Overwhelming Efficacy in Landmark Stem Cell Study for the Treatment of Diabetic Foot Ulcers Grafix closes three times as many wounds as standard of care - the largest relative improvement ever repor
Add to Reading List

Document Date: 2013-08-13 07:59:47

Open Document

File Size: 335,17 KB

Share Result on Facebook

Company

CPC Clinical Research / Osiris Therapeutics Inc. / Aziz Ahmad Osiris Therapeutics Inc. / /

Country

United States / /

/

Event

FDA Phase / Business Partnership / /

Facility

University of Texas Southwestern Medical Center / University of Colorado School / /

/

IndustryTerm

manufacturing / /

MedicalCondition

chronic diabetic foot ulcers / /

MedicalTreatment

cell therapy / /

Organization

University of Texas Southwestern Medical Center / United States Securities and Exchange Commission / University of Colorado / /

Person

Michelle LeRoux Williams / William R. Hiatt / C. Randal Mills / Larry Lavery / /

/

Position

investigator / Professor / President / Investigator and Professor / Chief Executive Officer / Officer / Chief / /

Product

Prochymal® / /

ProvinceOrState

Texas / Maryland / Colorado / /

Technology

cell therapy / stem cells / /

URL

www.Osiris.com / /

SocialTag